Jounce Therapeutics (JNCE)
NASDAQ:JNCE
Holding JNCE?
Track your performance easily

Jounce Therapeutics (JNCE) Financial Statements

0 Followers

Jounce Therapeutics Financial Overview

Jounce Therapeutics's market cap is currently ―. The company's EPS TTM is $; its P/E ratio is ―; Jounce Therapeutics is scheduled to report earnings on ―, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 22Sep 22Jun 22Mar 22Dec 21
Income Statement-
Total Revenue$ 82.00M$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit$ 82.00M----
EBIT$ 51.08M$ -31.41M$ -33.71M$ -37.46M$ -30.28M
EBITDA$ 51.67M$ -30.91M$ -33.15M$ -36.87M$ -29.64M
Net Income Common Stockholders$ 50.96M$ -31.00M$ -33.51M$ -37.37M$ -30.23M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 189.54M$ 128.61M$ 148.56M$ 155.42M$ 178.57M
Total Assets$ 212.55M$ 158.08M$ 188.90M$ 214.67M$ 252.70M
Total Debt$ 10.02M$ 10.95M$ 11.89M$ 12.81M$ 13.69M
Net Debt$ -179.52M$ -117.66M$ -136.68M$ -142.61M$ -164.88M
Total Liabilities$ 29.44M$ 28.72M$ 31.17M$ 25.71M$ 28.89M
Stockholders Equity$ 183.11M$ 129.36M$ 157.73M$ 188.96M$ 223.81M
Cash Flow-
Free Cash Flow$ 59.01M$ -31.78M$ -23.75M$ -33.27M$ -28.33M
Operating Cash Flow$ 59.23M$ -31.54M$ -23.41M$ -33.17M$ -28.20M
Investing Cash Flow$ 14.23M$ 30.91M$ 40.70M$ -2.36M$ -21.68M
Financing Cash Flow-$ 0.00$ 33.00K$ 409.00K$ 49.00K
Currency in USD

Jounce Therapeutics Earnings and Revenue History

Jounce Therapeutics Debt to Assets

Jounce Therapeutics Cash Flow

Jounce Therapeutics Forecast EPS vs Actual EPS

Currently, no data available
Please return soon. This page is being updated.
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis